Cancer Clinical Trial -AbbVie-M19-063

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) (VIALE-T)

Drug

Venetoclax, Azacitidine, Best Supportive Care (BSC)

Phase

Phase III

Condition

Acute myeloid leukemia

Keywords

Stem Cell Transplantation